Continuous use of GLP-1 receptor agonists in adults with type 2 diabetes was associated with a lower risk of major ...
The Food and Drug Administration approved a higher-dose version of a popular class of obesity drugs on Thursday, the latest expansion in a rapidly growing market for weight-loss treatments. The newly ...
When Target scrapped its DEI policies shortly after President Donald Trump took office, boycotts sprang up across the country. From church pulpits to community gatherings, the policy U-turn was widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results